Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 462

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 462
---
 $ | 690 | ​ | ​ | ​ | ​                   | ​ |          — | ​ | ​ | ​ | ​      | $ |    — | ​ | ​ | ​ | ​                        | $ | 140,000 | ​ | ​ | ​ | ​                  | $ | -14,883,124 | ​ | ​ | ​ | ​                         | $ | -14,742,434 | ​ | ​ |

The accompanying notes are an integral part of these financial statements. F-31

TABLE OF CONTENTS

IRIS ACQUISITION CORP
STATEMENTS OF CASH FLOWS

| ​                                                                                    
 ​                                                                                    
 Cash Flows from Operating Activities:                                                | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | December 31, 
 2023         
 ​            | ​ |           ​ | ​ | ​ 
 ​ | ​ 
 ​ | 2022 
 ​    | ​ |            ​ | ​ | ​ 
 ​ 
 ​ |
|:-------------------------------------------------------------------------------------|:--|:--|:-------------|:--|------------:|:--|:--|:--|:-----|:--|-------------:|:--|:--|
| Net (loss) income                                                                    | ​ | ​ | ​            | $ |  -1,226,218 | ​ | ​ | ​ | ​    | $ |   10,249,254 | ​ | ​ |
| Adjustments to reconcile net (loss) income to net cash used in operating activities: | ​ | ​ | ​            | ​ |           ​ | ​ | ​ | ​ | ​    | ​ |            ​ | ​ | ​ |
| Unrealized gain on change in fair value of warrant liabilities                       | ​ | ​ | ​            | ​ |    -566,202 | ​ | ​ | ​ | ​    | ​ |   -9,586,864 | ​ | ​ |
| Unrealized gain on change in fair value of derivative liability                      | ​ | ​ | ​            | ​ |    -102,226 | ​ | ​ | ​ | ​    | ​ |            — | ​ | ​ |
| Accretion of debt discount on related party loan                                     | ​ | ​ | ​            | ​ |     103,089 | ​ | ​ | ​ | ​    | ​ |            — | ​ | ​ |
| Forgiveness of unrelated vendor payables                                             | ​ | ​ | ​            | ​ |    -275,